Rexahn Pharma (RNN) Will Make Supinoxin Poster Presentations at ASCO 2016

Rexahn Pharma (RNN) Will Make Supinoxin Poster Presentations at ASCO 2016

Rexahn Pharmaceuticals, Inc. (NYSE: RNN) announced that the Company presented two posters on its investigational anti-cancer candidate, Supinoxin (RX-5902), at the American Society for Clinical Oncology (ASCO) 2016 Gastrointestinal Cancers …

(Visited 2 times, 1 visits today)
11
Like
Save

Comments

Comments are disabled for this post.